DK0850646T3 - Liposompræparater af indolocarbazol-derivater - Google Patents

Liposompræparater af indolocarbazol-derivater

Info

Publication number
DK0850646T3
DK0850646T3 DK97926234T DK97926234T DK0850646T3 DK 0850646 T3 DK0850646 T3 DK 0850646T3 DK 97926234 T DK97926234 T DK 97926234T DK 97926234 T DK97926234 T DK 97926234T DK 0850646 T3 DK0850646 T3 DK 0850646T3
Authority
DK
Denmark
Prior art keywords
indolocarbazole derivatives
liposome preparations
liposome
indolocarbazole
derivatives
Prior art date
Application number
DK97926234T
Other languages
English (en)
Inventor
Kunio Ito
Yasuki Kato
Masahiro Yamauchi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of DK0850646T3 publication Critical patent/DK0850646T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK97926234T 1996-06-18 1997-06-12 Liposompræparater af indolocarbazol-derivater DK0850646T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15645996 1996-06-18
PCT/JP1997/002033 WO1997048398A1 (fr) 1996-06-18 1997-06-12 Preparations liposomes de derives indolocarbazole

Publications (1)

Publication Number Publication Date
DK0850646T3 true DK0850646T3 (da) 2008-05-13

Family

ID=15628218

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97926234T DK0850646T3 (da) 1996-06-18 1997-06-12 Liposompræparater af indolocarbazol-derivater

Country Status (10)

Country Link
US (1) US6045822A (da)
EP (1) EP0850646B1 (da)
AT (1) ATE381932T1 (da)
AU (1) AU718856B2 (da)
CA (1) CA2229892C (da)
DE (1) DE69738416T2 (da)
DK (1) DK0850646T3 (da)
ES (1) ES2296311T3 (da)
PT (1) PT850646E (da)
WO (1) WO1997048398A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
EP1190705A4 (en) * 1999-06-24 2009-03-18 Kyowa Hakko Kogyo Kk METHOD OF REGULATING THE TREATMENT OF LABELED SUBSTANCE IN LIPOSOMES
ATE319428T1 (de) * 2000-12-07 2006-03-15 Univ Utrecht Holding Bv Zusammensetzung zur behandlung von entzündlichen erkrankungen
US7396852B2 (en) * 2005-11-16 2008-07-08 Xerox Corporation Compound having indolocarbazole moiety and divalent linkage
US20060124921A1 (en) * 2004-12-14 2006-06-15 Xerox Corporation Compound with indolocarbazole moieties and devices containing such compound
TWI468188B (zh) 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
JP5638204B2 (ja) * 2009-05-29 2014-12-10 国立大学法人 岡山大学 経口投与用リポソーム製剤およびその製造方法
EP2883542B1 (en) 2012-08-10 2019-05-01 Taiho Pharmaceutical Co., Ltd. Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007105A1 (en) * 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
JP2694701B2 (ja) * 1989-08-24 1997-12-24 日本油脂株式会社 液体膜制癌剤
IL100833A0 (en) * 1991-02-20 1992-09-06 Greenwich Pharma Method for synthesis of ethereally substituted blocked monosaccharides
JPH07278016A (ja) * 1994-04-13 1995-10-24 Pola Chem Ind Inc 抗癌剤リポソーム製剤
EP0711557A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage

Also Published As

Publication number Publication date
WO1997048398A1 (fr) 1997-12-24
DE69738416D1 (de) 2008-02-07
EP0850646A4 (en) 2005-06-22
US6045822A (en) 2000-04-04
EP0850646B1 (en) 2007-12-26
EP0850646A1 (en) 1998-07-01
CA2229892C (en) 2003-01-07
ES2296311T3 (es) 2008-04-16
CA2229892A1 (en) 1997-12-24
AU718856B2 (en) 2000-04-20
AU3106697A (en) 1998-01-07
DE69738416T2 (de) 2008-12-11
ATE381932T1 (de) 2008-01-15
PT850646E (pt) 2008-03-31

Similar Documents

Publication Publication Date Title
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
BR9804214A (pt) Compostos.
AU2001277753A1 (en) Phosphonocephem compound
DK0791007T3 (da) Antifungale sordaridinderivater
DK0695755T3 (da) Pyrrolocarbazoler
DK0850646T3 (da) Liposompræparater af indolocarbazol-derivater
ATE232528T1 (de) Pyrimidinylpyrazolderivate
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
FI952420A (fi) Glukopyranosidibentsotiofeenit
EP0990649A4 (en) BENZOYLPYRAZOLE DERIVATIVES COMPRISING DEFINED SUBSTITUTES AND HERBICIDES THUS OBTAINED
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FI910366A0 (fi) Menetelmä deoksimulundokandiinin valmistamiseksi
BR9902096A (pt) Pitazóis.
GB9921578D0 (en) Omeprazole synthesis
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
DE69615814T2 (de) Uch-15-verbindungen
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων